The 27th Congress of the European Hematology Association (EHA) 2022, held in Vienna, Austria, and virtually, from 9 - 12 June 2022, saw leading experts from around the world gather to discuss the most exciting updates in the field of hematology. Key updates on CAR-T therapy, transplant research, novel drugs, and more were showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalassemia, and beyond.  
View all videos

EHA 2022

EHA 2022
09–12 June 2022 | Vienna Austria / Online

Our report of first-in-human GPRC5D-targeted CAR T cells for MM is out in NEJM! The trial was led by Sham Mailankody and could not be done without the amazing clinical, correlative science, stats, & cell manufacturing teams.
Happy to share our bench>bedside journey
1/10

Very excited to see this incredible work led by Sham Mailankody and @ESmithMDPhD published in @NEJM. An incredible bench-to-bedside story leading to real progress for our patients. Looking forward to seeing what comes next. https://www.nejm.org/doi/full/10.1056/NEJMoa2209900

It’s the second day of #SOHO22 & we’re so happy to be here in-person, speaking with several experts at the forefront of hematology.👨‍⚕️👩‍⚕️

Stay tuned for our exclusive interviews!🎥

@SocietyofHemOnc #MMsm #LeuSM #AMLsm #ALLsm #LymSM #MDSsm #MPNsm #CLLsm #ImmunoOnc #HemOnc

📣Join us for another weekly podcast!

Tune in as experts Amer Zeidan, Rena Buckstein, and Valeria Santini discuss key updates from iwMDS 2022!

Listen here:

🎧: http://ow.ly/YIf050KWGwR

#HemOnc #MDSsm #BloodCancerAwarenessMonth

Load More...

EHA 2022

EHA 2022
09–12 June 2022 | Vienna Austria / Online
The 27th Congress of the European Hematology Association (EHA) 2022, held in Vienna, Austria, and virtually, from 9 - 12 June 2022, saw leading experts from around the world gather to discuss the most exciting updates in the field of hematology. Key updates on CAR-T therapy, transplant research, novel drugs, and more were showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalassemia, and beyond.  
View all videos

Our report of first-in-human GPRC5D-targeted CAR T cells for MM is out in NEJM! The trial was led by Sham Mailankody and could not be done without the amazing clinical, correlative science, stats, & cell manufacturing teams.
Happy to share our bench>bedside journey
1/10

Very excited to see this incredible work led by Sham Mailankody and @ESmithMDPhD published in @NEJM. An incredible bench-to-bedside story leading to real progress for our patients. Looking forward to seeing what comes next. https://www.nejm.org/doi/full/10.1056/NEJMoa2209900

It’s the second day of #SOHO22 & we’re so happy to be here in-person, speaking with several experts at the forefront of hematology.👨‍⚕️👩‍⚕️

Stay tuned for our exclusive interviews!🎥

@SocietyofHemOnc #MMsm #LeuSM #AMLsm #ALLsm #LymSM #MDSsm #MPNsm #CLLsm #ImmunoOnc #HemOnc

📣Join us for another weekly podcast!

Tune in as experts Amer Zeidan, Rena Buckstein, and Valeria Santini discuss key updates from iwMDS 2022!

Listen here:

🎧: http://ow.ly/YIf050KWGwR

#HemOnc #MDSsm #BloodCancerAwarenessMonth

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter